InvestorsHub Logo
Followers 0
Posts 20
Boards Moderated 0
Alias Born 10/11/2014

Re: None

Monday, 10/13/2014 1:27:16 PM

Monday, October 13, 2014 1:27:16 PM

Post# of 12450
Chemist72. Do you have any stocks?
I got an interesting and long email from the Orexo CEO Nikolaj Sørensen today.


Bunavail will be launch in November according to BDSI.
Its potential of competing with Orexos Zubsolv he says depends on what kind of deals BDSI will reach with insurance companies and what the doctors prefer. Up to date they dont have any known deals with insurance companies that he knew.

Mr Sørensen explained Bunavail as a patch that you apply towards the cheek intraorally. It takes 15 min to dissolve!!!

From BDSIs website.

"BEMA® films are designed to:

Adhere to oral mucosa in less than 5 seconds
Optimize delivery across the oral mucosa
Completely dissolve within 15 to 30 minutes"

!!!!!!


He said that having it in a patch gives it the advantage:

-Less buprenorfin to achieve the same effect in comparision to Suboxone and partially Zubsolv. Disadvantage for BDSI/Bunavail is that they have to explain that 4,1mg is equal Suboxone 5,7mg.


He also said that he believes that Reckitt Benckiser will make a deal with Par/Intelgenx on the generica.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News